From: Application of the amplification-free SERS-based CRISPR/Cas12a platform in the identification of SARS-CoV-2 from clinical samples
Samples diagnosed using RT-qPCR
Positive
Negative
Total
S-CRISPR
21
0
3
88
91
24
112